Taken together, our data suggest investigations of serum UCP2 levels as a biomarker of vascular risk in large datasets of T2DM patients together with further work to better delineate the relationship between UCP2 and vascular function are both warranted. The gene discussed is UCP2; the disease is type 2 diabetes mellitus.